ConductScience.org, home

Paper34522017

The tangled history of mRNA vaccines.

Dolgin E. Nature, 2021. Cited by 306 papers, by iCite.

Cite this record

ConductScience Library. The tangled history of mRNA vaccines. Papers, record 34522017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34522017

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The tangled history of mRNA vaccines.
PubMed
Journal
Nature
PubMed
Year
2021
PubMed
Publication types
Historical Article, Journal Article
PubMed
Citations, by iCite
306
iCite
Relative citation ratio, by iCite
16.1
iCite
Revised in PubMed
2026-10-12
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dolgin EElie

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19 VaccinesMajor topic
Drug IndustryMajor topic
ResearchMajor topic
Research PersonnelMajor topic
Vaccines, SyntheticMajor topic
Animals
Clinical Trials as Topic
Genetic Therapy
History, 20th Century
History, 21st Century
Humans
Liposomes
Mice
Nanoparticles
Neoplasms
Nobel Prize
Patents as Topic
Pseudouridine
RNA
RNA Stability
Rabbits
Spike Glycoprotein, Coronavirus
Toll-Like Receptors
Vaccines, DNA
mRNA Vaccines

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110602021In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies.Eur J Immunol2000https://conductscience.org/library/papers/10602021PubMed
222908294Nonviral delivery of self-amplifying RNA vaccines.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22908294PubMed
315835741A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA.Pharm Res2005https://conductscience.org/library/papers/15835741PubMed
410455412Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA.Gene Ther1999https://conductscience.org/library/papers/10455412PubMed
56091052Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.Nucleic Acids Res1984https://conductscience.org/library/papers/6091052PubMed
617476302Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent.Gene Ther2007https://conductscience.org/library/papers/17476302PubMed
7683336Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes.Nature1978https://conductscience.org/library/papers/683336PubMed
820888316Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.Cell Stem Cell2010https://conductscience.org/library/papers/20888316PubMed
933487468Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial.Vaccine2021https://conductscience.org/library/papers/33487468PubMed
1034378087Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial.Wien Klin Wochenschr2021https://conductscience.org/library/papers/34378087PubMed
118760800Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.J Exp Med1996https://conductscience.org/library/papers/8760800PubMed
1216111635Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.Immunity2005https://conductscience.org/library/papers/16111635PubMed
1314729660mRNA is an endogenous ligand for Toll-like receptor 3.J Biol Chem2004https://conductscience.org/library/papers/14729660PubMed
147882341Characterization of a messenger RNA polynucleotide vaccine vector.Cancer Res1995https://conductscience.org/library/papers/7882341PubMed
151690918Direct gene transfer into mouse muscle in vivo.Science1990https://conductscience.org/library/papers/1690918PubMed
169518670Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA.Biochim Biophys Acta1998https://conductscience.org/library/papers/9518670PubMed
17683335Evidence for translation of rabbit globin mRNA after liposome-mediated insertion into a human cell line.Nature1978https://conductscience.org/library/papers/683335PubMed
188325342Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.Eur J Immunol1993https://conductscience.org/library/papers/8325342PubMed
196207484Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs.Nucleic Acids Res1984https://conductscience.org/library/papers/6207484PubMed
201546298Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA.Science1992https://conductscience.org/library/papers/1546298PubMed

See all 21 referencesDownload CSV of references

Cited by237

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 306 citations.

PMIDTitleJournalYearIn PapersSource
42780913Codon-dependent translation of N1-ethylpseudouridine-modified mRNA reduces innate immunity while preserving vaccine immunogenicity.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42780913PubMed
42736202Astragalus polysaccharides alleviate LPS-induced inflammatory injury in the avian macrophage cell line HD11 via the TLR2/PI3K/AKT/NF-κB signaling pathway.Poult Sci2026https://conductscience.org/library/papers/42736202PubMed
42719780Current landscape and future directions of neoantigen vaccines: A new era of personalized cancer immunotherapy.Innovation (Camb)2026https://conductscience.org/library/papers/42719780PubMed
42533521Characterization of Short Production Cycle and Nongenotoxic mRNA-Based CAR-T Cells Targeting CD19-Positive and CD22-Positive Malignancies.J Immunol Res2026https://conductscience.org/library/papers/42533521PubMed
42506664Beyond PrEP: The Imperative for an HIV Vaccine to End the Epidemic in Africa.Vaccines (Basel)2026https://conductscience.org/library/papers/42506664PubMed
42505558From Pandemic Innovation to Platform Diversification: A Systematic Review of Clinical and Preclinical Development of Non-SARS-CoV-2 mRNA Vaccines.Diseases2026https://conductscience.org/library/papers/42505558PubMed
42369559mRNA vaccines against viral pathogens: molecular design, delivery systems, and clinical applications.Front Microbiol2026https://conductscience.org/library/papers/42369559PubMed
42236989Towards mRNA therapeutics 2.0.Nat Rev Drug Discov2026https://conductscience.org/library/papers/42236989PubMed
42215480Polypeptide-engineered lipid nanoparticles for mRNA delivery with limited immunogenicity.Nat Commun2026https://conductscience.org/library/papers/42215480PubMed
42152524Macrophage Immune Responses in Viral Infections: Functional Plasticity and Therapeutic Targeting.J Microbiol Biotechnol2026https://conductscience.org/library/papers/42152524PubMed
42100852Generation of precise and accurate engineered circRNAs using enzymatic ligation.Nucleic Acids Res2026https://conductscience.org/library/papers/42100852PubMed
42057181Bridging functional bionanomaterials and the clinic: strategic communication as a translational enabler.J Nanobiotechnology2026https://conductscience.org/library/papers/42057181PubMed
41932444A systematic review on vaccine developmental approaches: Evaluating efficacy, and addressing challenges of infectious diseases in the post-COVID-19 era.Virus Res2026https://conductscience.org/library/papers/41932444PubMed
41920287mRNA vaccines in cancer immunotherapy: current progress and perspectives in solid tumors and hematologic malignancies.MedScience2026https://conductscience.org/library/papers/41920287PubMed
41893758Circular RNA as a New Vaccine Platform: Considerations, Challenges, and Perspectives.Vaccines (Basel)2026https://conductscience.org/library/papers/41893758PubMed
41889911Structure-Activity Mapping of Intraperitoneal mRNA-LNPs: Decoupling Tumor and Liver Biodistribution in Pancreatic Cancer.bioRxiv2026https://conductscience.org/library/papers/41889911PubMed
41881999Cancer vaccines and RNA therapeutics: exploring the impact of microRNAs.NPJ Vaccines2026https://conductscience.org/library/papers/41881999PubMed
41878421GenIV vaccines: bridging innovation to equity in neglected tropical diseases.Front Immunol2026https://conductscience.org/library/papers/41878421PubMed
41809895The strategies and advances of mRNA translation booster.Asian J Pharm Sci2025https://conductscience.org/library/papers/41809895PubMed
41808349Respiratory syncytial virus mRNA vaccine-induced immunity and protection against subgroups A and B in mice.Immunohorizons2026https://conductscience.org/library/papers/41808349PubMed

See all 237 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34522017

GET https://conductscience.org/api/papers/v1/34522017/references?page=2